David A. Sadock cofounded ETHOS Health Communications with Anita O’Connor in 2002. As Chief Executive Officer, David focuses on long-term initiatives designed to ensure the financial growth and health of the company. Toward that end, he monitors the pharmaceutical and biotechnology industries to determine how best to position ETHOS for success. David is also charged with developing the company’s marketing efforts and transforming our work into recognizable products and services that differentiate ETHOS from its competitors.

In addition, David is an active leader in neuroscience research and development as a member of the Board of Directors of the Epilepsy Therapy Project (www.epilepsy.com/epilepsy_therapy_project). The Epilepsy Therapy Project is a not-for-profit corporation dedicated to a singular focus: overcoming the funding gaps and roadblocks that slow the progress of new therapies from the lab to the patient.

Before he cofounded ETHOS, David was Executive Vice President of Sales and Marketing for HealthAnswers Education, North Wales, Pennsylvania. Prior to this, he worked for Bristol-Myers Squibb for 12 years in positions of increasing responsibility in sales, senior sales management, and brand marketing. Most notably, he served as Brand Director in the company’s Neuroscience Marketing Division. David received his degree in biochemistry in 1988 from the University of Scranton, where he graduated a Presidential and Mitrani Scholar.

Along with David Sadock, Ms. O’Connor founded ETHOS Health Communications in 2002. As President, Anita is directly responsible for ensuring that ETHOS delivers on its goals of providing superior strategic and scientific thinking, precise planning, and excellence in execution in medical education programming. With an extensive background in strategic consulting, Anita is able to make creative and strategic recommendations to help clients achieve their objectives, and her experience supports and strengthens our commitment to providing superior service to all clients. She remains dedicated to building an outstanding company that delivers valuable and meaningful medical education programs to health care practitioners to improve patient outcomes.

Prior to cofounding ETHOS, Anita held positions of leadership at HealthAnswers Education and Arthur Andersen. Anita received her degree in accounting from Villanova University in 1987 and earned her CPA license in 1990.

Thomas Dougherty joined ETHOS Health Communications in 2011. Tom aggressively plans, organizes, directs, and supervises all aspects of financial operations, including budgeting, forecasting, and reporting. Tom is instrumental in analyzing potential client acquisitions and alliances, as well as the revenue potential for new product and service lines.

Before joining ETHOS, Tom served as Regional Chief Financial Officer for a pharmaceutical services company. During his 17 years with the company, Tom helped facilitate its growth from a privately held company to the prized acquisition of a publicly traded company, where he became Executive Vice President of Finance.

Tom holds a bachelor of science degree in accounting from Villanova University and a master of business administration degree in finance from Widener University.

Nathan P. Wible received a doctor of pharmacy degree from the Philadelphia College of Pharmacy (PCP), where he graduated as valedictorian. During his time at PCP, he trained in various practice settings, including a medical center on an Indian reservation with the Indian Health Service of the US Public Health Service, the Global Medical Information Department at Eli Lilly, and Promotional Regulatory Affairs with AstraZeneca Pharmaceuticals. Dr. Wible also worked with an international HIV/AIDS prevention program with the Department of the Navy in Hawaii. There he interacted with high-ranking international and domestic military officials as well as representatives of the World Health Organization and Centers for Disease Control and Prevention.

Subsequently, Dr. Wible carried these impressive experiences into a clinical pharmacist position at the Hospital of the University of Pennsylvania (HUP). While there, he trained in a wide variety of disciplines, focusing on oncology, critical care, anticoagulation, and cardiothoracic surgery. His work in anticoagulation and cardiothoracic surgery earned Dr. Wible a newly created position as an inpatient anticoagulation specialist at HUP. In that capacity, he was responsible for building and developing an inpatient anticoagulation service for the Pharmacy Department and hospital. Dr. Wible quickly transformed the service from an unknown entity with a small reach in the hospital to a highly desired consultation service receiving requests from all medical and surgical services. That service continues to operate today, covering anticoagulation for the entire hospital and saving the hospital a significant amount of money each year.

Dr. Wible entered the medical communications field with an intense desire to translate the science of medicine into clinical benefit for patients. At ETHOS Health Communications, Dr. Wible combines his extensive knowledge, clinical experience and skills, business acumen, and strategic thinking to implement highly effective educational programs. He has led and managed successful client relationships in multiple sclerosis (MS), rheumatology, and oncology. In addition, he has worked on client teams for other important programs in rheumatology (arthritis and bone), oncology, neuroscience, and pain. During his work at ETHOS, Dr. Wible has had a wide range of experiences, from new product commercialization to launch to life-cycle management. Most recently, he helped to successfully launch a breakthrough and potential future blockbuster new product into the MS space and is currently supporting that product post-launch.

In his current role, Dr. Wible oversees our Strategic Services team, which is responsible for revenue generation and account management.

As Executive Vice President of Strategic Scientific Communications at ETHOS Health Communications, Jim Loss is responsible for translating science into clinical benefit for patients. In the course of pursuing this daily imperative, he applies his scientific knowledge, extensive laboratory research training, and professional experience to provide medical expertise, strategies, and perspective to clients who are developing and/or marketing pharmacologic/biologic agents. Jim Loss is responsible for supervising and training the company’s writing and editorial team. While overseeing publication planning at ETHOS, he ensures adherence to industry standards, such as Good Publication Practice and International Committee of Medical Journal Editors (ICMJE) Guidelines.

Dr. Loss is able to offer strong and decisive business proposals to clients and provide guidance to his colleagues as a result of his work experience and involvement in the International Society for Medical Publication Professionals (ISMPP). In addition to earning his qualification as a Certified Medical Publication Professional (CMPP™), Dr. Loss is currently a volunteer member of the ISMPP Ethics Committee.

Dr. Loss earned a bachelor of arts degree in biology from Temple University, where he also began his research training. Between his undergraduate and graduate training, Dr. Loss worked as Quality Assurance Auditor at Argus Research Labs, where he was responsible for reviewing all written materials, from initial protocol to final report, to ensure that they complied with all governmental regulations and the facility’s standard operating procedures, accurately described in-life critical phases, and matched the raw data.

Dr. Loss earned a doctoral degree in pharmacology and toxicology from the Philadelphia College of Pharmacy and Science. His graduate work focused primarily on pulmonary pharmacology (asthma), where he studied the effects of chronic beta-2 agonist administration on airway smooth muscle hyperreactivity. His postdoctoral research at the Emory University School of Medicine broadened his research training to molecular biology, where he studied how extracellular receptor-mediated cell signaling regulates gene expression and mRNA stability of IL-6 in vascular smooth muscle cells. His graduate and postdoctoral research is published in several peer-reviewed journals and an invited book chapter, and he has presented his work in national and international forums.

Dr. Loss has experience with preclinical and clinical data, pharmacogenomics, and patient-reported outcomes in the development of a wide range of medical communication materials for a variety of audiences (eg, primary care physicians, nurses, and managed care). These communication vehicles include medical publications (eg, primary papers, reviews, abstracts, posters, and slides), medical education materials (eg, drug information and continuing education monographs), field force materials, sales training materials, and promotional pieces. He also has experience with communication and publication plans, symposia medical direction and development of enduring materials, advisory board and clinical investigator meetings, and opinion leader identification.

These communication materials have been developed in support of agents for Crohn’s disease, hematologic malignancies, solid tumors, idiopathic thrombocytopenic purpura, hemostasis disorders, diabetes, pain management, rheumatoid arthritis, and men’s health, in addition to surgical devices and several different biosurgicals used to achieve hemostasis.

As Vice President of Program Management at ETHOS Health Communications, Kathleen M. Laurie oversees the effective and successful delivery of the medical and promotional programs that the company develops. Ms. Laurie defines, communicates, and measures key goals and expectations for all program managers and program coordinators; coordinates and streamlines workflow; develops and implements training programs; monitors program delivery for quality and efficiency; and develops methods of ensuring continuous process improvement. In this capacity, she ensures the application of corporate standards of excellence. Ms. Laurie also plays a key role in new business development initiatives for current and potential customers.

Ms. Laurie’s substantial management expertise, deep industry knowledge, and great skill in planning and executing programs have resulted in their efficient and successful delivery. Her dedication to and focus on management drives our outstanding reputation. Before joining ETHOS, Ms. Laurie served as Field Support Engineer, National Training Manager, and Business Unit Manager for Abbott Laboratories. She also owned and operated Infocus Marketing Services, a consulting company providing research and marketing services to the hospital and health care markets.

Warren A. Katz, MD, is Executive Vice President, Medical Affairs, responsible for leadership in running his department, quality oversight, and professional networking.

Before joining ETHOS Health Communications, Dr. Katz was Chief of Rheumatology and Chairman of Medicine for more than 12 years at the Penn Presbyterian Medical Center of the University of Pennsylvania Health System in Philadelphia. He continues to serve as Adjunct Professor of Medicine at the University of Pennsylvania School of Medicine. Dr. Katz is board-certified in both internal medicine and rheumatology.

After earning a medical degree from Jefferson Medical College in Philadelphia, Dr. Katz completed an internship at the Albert Einstein Medical Center in Philadelphia. He then completed residencies in medicine at Boston City Hospital and Mount Sinai Hospital in New York. He was awarded a fellowship in rheumatic diseases at Tufts-New England Medical Center in Boston and held another teaching fellowship in rheumatic diseases at New York University Medical Center. It was there that he started his research in the role of connective tissue metabolism in the urate deposition phenomenon of gout.

During his entire career, Dr. Katz has been actively involved in professional education. He has written numerous abstracts, articles, book chapters, and electronic (CD-ROM and Internet) programs on subjects related to rheumatology, osteoporosis, and musculoskeletal pain management. He often is invited to lecture or lead symposia on these topics at national and international conferences.

Dr. Katz has served on the editorial review boards for several medical journals, including Annals of Internal Medicine and Journal of Rheumatology and was Section Editor of Current Opinion in Rheumatology. He is the author of Diagnosis and Management of Rheumatic Diseases (Lippincott Williams & Wilkins) and Pain Management in Rheumatologic Disorders: A Guide for Clinicians (Drugsmartz Pub). Dr. Katz is past-president of the Philadelphia Rheumatism Society, President of the Eastern Pennsylvania Chapter of the Arthritis Foundation, and a life fellow of both the American College of Physicians and the American College of Rheumatology. Currently, he serves on the board of directors of the Pennsylvania Rheumatism Society and is a member of the American College of Rheumatology and the Osteoarthritis Research Society International.

Dr. Katz is recognized as a medical education and strategic planning consultant to the pharmaceutical industry. He is a proponent of interactive teaching methods and has developed many interactive teaching programs in various media forms. Dr. Katz uses these methods in his own presentations worldwide.

Among Dr. Katz’s many accolades is the prestigious Dr. Joseph Lee Hollander Award for Excellence and Achievement in Rheumatology, presented by the Eastern Pennsylvania Chapter of the Arthritis Foundation. He has been recognized as a “Best Doctor” by Philadelphia and Town & Country magazines and by Best Doctors in America. He has been listed in Who’s Who in Science, Who’s Who in America, and Who’s Who in the World.

Patricia D. Kelly, PHR, joined ETHOS Health Communications in April 2011 as the company’s first Director of Human Resources. She has an extensive background in legal and compliance issues in the human resources (HR) arena. Prior to joining ETHOS, Ms. Kelly was an employee of Advanta Corporation for 15 years, serving as both an employment law paralegal and Director of Employee Relations. Her expertise includes development of HR strategy to align with corporate goals and objectives including performance management, leadership coaching, workforce planning, and organizational design and development.

At ETHOS, Ms. Kelly designs, implements, and administers HR policies and activities to help meet our company objectives and promote a motivational climate, including opportunities for career growth and development. She manages the compensation and benefits programs, directs the recruiting process, oversees the annual review process, and develops effective procedures for all central HR administration.

Ms. Kelly received her certification as a Professional in Human Resource Management through the Human Resource Certification Institute and Villanova University, Villanova, Pennsylvania. Her certification in paralegal studies is from Widener University, Chester, Pennsylvania.

In her role as Director of Strategic Scientific Communications, Tammy Grow maintains the quality of content developed by the department and actively manages the Scientific Directors, Editors, and Graphics personnel. Dr. Grow also works in collaboration with ETHOS strategic consultants to stay abreast of current research and other changes in the marketplace that affect the therapeutic area and brands.

Dr. Grow is an immunologist with a wealth of experience from academia and medical communications. She received her doctoral degree in microbiology and immunology from Temple University School of Medicine in Philadelphia. During her postdoctoral studies, Dr. Grow gained additional experience in neurovirology, physiology, and molecular biology. She is well published and has presented her research at a number of scientific congresses. Prior to this, she obtained her master’s degree in medical microbiology and was an adjunct professor in the Department of Biology at Long Island University in Brooklyn, New York.

As a member of the Center for Substance Abuse Research Dr. Grow was instrumental in studying the cross-talk between the immune and nervous systems. She pioneered studies on the effects of opiate withdrawal on the immune system and was actively involved in studies that established a relationship between co-receptors for HIV and receptors for pain medicines such as morphine. Dr. Grow has worked in various therapeutic areas, including neurology (Parkinson’s disease), diabetes, antimicrobials, oncology, vaccines, and cardiology (antihypertensives). She has been instrumental in the development of supplements and review and primary manuscripts in these various areas and has guided junior writers. In addition to her vast experience in publications/publication planning, Dr. Grow has developed deliverables for speaker training and other promotional meetings.

Dr. Grow is also a member of the International Society for Medical Publication Professionals (ISMPP) and has a strong interest in policies and guidelines that govern the roles/responsibilities of medical writers. Recently, Dr. Grow was a speaker at the ISMPP Annual meeting and presented on Good Publication Practices.

As Director of Business Development, Brian Strike’s responsibilities include all activities related to identifying and cultivating new business opportunities to expand and grow ETHOS’ client base. As a member of the leadership team at ETHOS, Mr. Strike heads new business development and planning, as well as communicates ETHOS’ value as a strategic partner to medical and marketing clients in the pharmaceutical industry. Mr. Strike also contributes to the formulation of business and marketing plans, and to the development of new products and services. This includes the creation of marketing strategies and messaging that establish ETHOS as a strategic partner with valued experience and a solid reputation.

Mr. Strike is a highly motivated and results-driven sales and marketing professional with a track record of creating new business accounts and expanding relationships to drive revenue. He has more than 13 years of experience in the pharmaceutical sector. Prior to joining ETHOS in 2012, Mr. Strike worked at Medical Communications Media, a leading medical education and communications company. During his 9-year tenure, he held positions of increasing scope and responsibility. Starting as an account executive and culminating as Director-Medical Education, Mr. Strike expanded his responsibilities from sales and account management to later include marketing, new product development, and staff administration. Mr. Strike began his career in health care as a sales representative and field sales trainer for Mylan Bertek Pharmaceuticals. He earned his bachelor of science degree in marketing from Ithaca College.

As Director of Information Technology at ETHOS Health Communications, Shaun R. Schanbacher is responsible for managing IT operations, adding new technology features to increase efficiency and solve business problems, and capacity planning for the ever-growing ETHOS network.

Before joining ETHOS, Mr. Schanbacher served as a network administrator at a global distribution company for 7 years. In this capacity, he was heavily involved in all aspects of maintaining, supporting, and upgrading the enterprise IT network for the company’s 5,000 employees. After Mr. Schanbacher joined ETHOS in 2009 as Information Technology Manager, he used the experience gained in his former role to enhance ETHOS’ IT infrastructure and enrich user support. His efforts quickly led to successful outcomes for ETHOS’ employees and clients and to his promotion to Director of Information Technology. Additionally, Mr. Schanbacher has been the leader of several internal teams charged with transforming innovative concepts into tools that benefit clients.

Mr. Schanbacher is a graduate of the The iSchool at Drexel University's College of Information Science and Technology, a recognized leader in this field. He also takes continuing education courses to update his skills and challenge his mind.